Of particular interest is TREM-1, which has been previously reported to accentuate lung injury during ARDS and has shown promise as an inflammatory biomarker and as therapeutic target for sepsis and septic shock [26,27]. This evidence concerns the gene TREM1 and acute respiratory distress syndrome.